Healthcare Startup myLAB Box Raises $1.56M in Seed

mylabmyLAB Box, a Los Angeles, California-based at-home STD testing service, raised $1.56M in seed funding.

The round was led by K5 Ventures and Texas Halo Fund with participation from Morgan Stanley (who selected the startup to participate in their Multicultural Innovation Lab), Pasadena Angels, Pipeline Angels, and Sand Hill Angels.

The company, which has now raised $2.1m in total funding, intends to use the capital to expand product offerings while increasing access to the service.

Founded in 2013 by Lora Ivanova, CEO, myLAB Box offers a nationwide at-home screening platform for STDs. All myLAB Box tests are validated by fully licensed CLIA-certified lab affiliates with experience in testing for infectious diseases.
The company currently offers a comprehensive test selection for STDs, including (but not limited to) Chlamydia, Gonorrhea, HIV, Herpes, Syphilis, and HPV.

The kits range in price from $79 to $499, and are available via the website, or at retail partners Amazon, Target, and Walmart.



Join the discussion